$ARVN
Arvinas Inc Stock $arvn

$arvn Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000165575922000016 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q1
Revenue	$24.20M	$26.33M	$5.500M
YoY Change	340.0%	1086.1%	-11.85%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$20.20M	$18.86M	$12.32M
YoY Change	63.96%	54.19%	55.36%
% of Gross Profit
Research & Development	$64.00M	$61.92M	$34.90M
YoY Change	83.38%	86.5%	60.63%
% of Gross Profit
Depreciation & Amortization	$1.500M	$1.288M	$1.150M
YoY Change	30.43%	21.51%	85.48%
% of Gross Profit
Operating Expenses	$84.20M	$80.78M	$47.20M
YoY Change	78.39%	77.8%	59.18%
Operating Profit	-$60.00M		-$41.70M
YoY Change	43.88%		78.11%
Interest Expense	$1.200M	$653.4K	$430.0K
YoY Change	179.07%	30.68%	2546.15%
% of Operating Profit
Other Income/Expense, Net	$1.100M	$796.5K	$700.0K
YoY Change	57.14%	-31.34%	-58.16%
Pretax Income	-$58.90M	-$53.00M	-$40.96M
YoY Change	43.8%	27.55%	88.41%
Income Tax	$4.500M		$0.00
% Of Pretax Income
Net Earnings	-$63.40M	-$53.00M	-$41.00M
YoY Change	54.63%	27.55%	88.6%
Net Earnings / Revenue	-261.98%	-201.27%	-745.45%
Basic Earnings Per Share	-$1.20		-$0.84
Diluted Earnings Per Share	-$1.20	-$1.006M	-$0.84
COMMON SHARES
Basic Shares Outstanding	53.00M shares		48.60M shares
Diluted Shares Outstanding	53.00M shares		48.60M shares

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.428B	$1.503B	$651.3M
YoY Change	119.32%	118.24%	147.83%
Cash & Equivalents	$62.30M	$108.3M	$346.1M
Short-Term Investments	$1.366B	$1.394B	$305.2M
Other Short-Term Assets	$21.90M	$24.20M	$8.200M
YoY Change	167.07%	296.72%	134.29%
Inventory
Prepaid Expenses
Receivables	$0.00	$15.00M	$0.00
Other Receivables	$6.700M	$10.70M	$5.200M
Total Short-Term Assets	$1.457B	$1.553B	$664.7M
YoY Change	119.2%	120.81%	146.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.40M	$12.70M	$12.21M
YoY Change	9.74%	3.25%	27.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$0.00
YoY Change
Other Assets	$12.10M	$12.50M	$0.00
YoY Change			-100.0%
Total Long-Term Assets	$31.30M	$29.10M	$17.10M
YoY Change	83.04%	103.5%	39.54%
TOTAL ASSETS
Total Short-Term Assets	$1.457B	$1.553B	$664.7M
Total Long-Term Assets	$31.30M	$29.10M	$17.10M
Total Assets	$1.488B	$1.582B	$681.8M
YoY Change	118.29%	120.46%	141.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.600M	$31.30M	$9.000M
YoY Change	-4.44%	340.85%	197.93%
Accrued Expenses	$30.20M	$23.10M	$8.001M
YoY Change	277.44%	22.22%	17.95%
Deferred Revenue	$197.5M	$206.2M
YoY Change		828.83%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$238.0M	$261.7M	$40.40M
YoY Change	489.11%	431.91%	21.8%
LONG-TERM LIABILITIES
Long-Term Debt	$1.000M	$1.000M	$2.000M
YoY Change	-50.0%	-50.0%	0.0%
Other Long-Term Liabilities	$526.0M	$537.2M	$24.10M
YoY Change	2082.57%	2138.33%	-32.3%
Total Long-Term Liabilities	$1.000M	$1.000M	$26.10M
YoY Change	-96.17%	-50.0%	1205.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$238.0M	$261.7M	$40.40M
Total Long-Term Liabilities	$1.000M	$1.000M	$26.10M
Total Liabilities	$765.0M	$799.9M	$66.50M
YoY Change	1050.38%	963.7%	-6.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$746.3M	-$682.9M
YoY Change		38.83%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$723.3M	$781.7M	$615.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.488B	$1.582B	$681.8M
YoY Change	118.29%	120.46%	141.39%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	-$63.40M	-$53.00M	-$41.00M
YoY Change	54.63%	27.55%	88.6%
Depreciation, Depletion And Amortization	$1.500M	$1.288M	$1.150M
YoY Change	30.43%	21.51%	85.48%
Cash From Operating Activities	-$57.10M	-$35.75M	-$39.00M
YoY Change	46.41%	23.21%	130.09%
INVESTING ACTIVITIES
Capital Expenditures	$2.100M	-$1.895M	$1.000M
YoY Change	110.0%	1.88%	-26.59%
Acquisitions
YoY Change
Other Investing Activities	$10.70M	-$113.7M	-$206.8M
YoY Change	-105.17%	-293.7%	-571.57%
Cash From Investing Activities	$8.600M	-$115.6M	-$207.8M
YoY Change	-104.14%	-303.37%	-589.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.500M	3.999M	$4.500M
YoY Change	-44.44%	-99.15%	233.21%
NET CHANGE
Cash From Operating Activities	-$57.10M	-35.75M	-$39.00M
Cash From Investing Activities	$8.600M	-115.6M	-$207.8M
Cash From Financing Activities	$2.500M	3.999M	$4.500M
Net Change In Cash	-$46.00M	-147.4M	-$242.3M
YoY Change	-81.02%	-129.51%	-1000.9%
FREE CASH FLOW
Cash From Operating Activities	-$57.10M	-$35.75M	-$39.00M
Capital Expenditures	$2.100M	-$1.895M	$1.000M
Free Cash Flow	-$59.20M	-$33.86M	-$40.00M
YoY Change	48.0%	24.67%	118.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001655759
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P9M
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-38672
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	ARVINAS, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2566120
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	5 Science Park
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	395 Winchester Ave
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New Haven
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06511
CY2022Q1	dei	City Area Code CityAreaCode	203
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	535-1456
CY2022Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share
CY2022Q1	dei	Trading Symbol TradingSymbol	ARVN
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	53165962	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62300000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	108300000	USD
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	4500000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	4500000	USD
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1366100000	USD
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1394300000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15000000.0	USD
CY2022Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	6700000	USD
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	10700000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17400000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19700000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	1457000000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1552500000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13400000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12700000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5800000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3900000	USD
CY2022Q1	arvn	Collaboration Contract Asset And Other Assets CollaborationContractAssetAndOtherAssets	12100000	USD
CY2021Q4	arvn	Collaboration Contract Asset And Other Assets CollaborationContractAssetAndOtherAssets	12500000	USD
CY2022Q1	us-gaap	Assets Assets	1488300000	USD
CY2021Q4	us-gaap	Assets Assets	1581600000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	8600000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	31300000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30200000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23100000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	197500000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	206200000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1700000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1100000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	238000000.0	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	261700000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	521900000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	534300000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000.0	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000.0	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4100000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2900000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	765000000.0	USD
CY2021Q4	us-gaap	Liabilities Liabilities	799900000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53100000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53100000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53000000.0	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53000000.0	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-746300000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-682900000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1488300000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1469200000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-18700000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4600000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	723300000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	781700000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1488300000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1581600000	USD
CY2022Q1	us-gaap	Revenues Revenues	24200000	USD
CY2021Q1	us-gaap	Revenues Revenues	5500000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	64000000.0	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34900000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20200000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12300000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	84200000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	47200000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-60000000.0	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-41700000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-100000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	200000	USD
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1200000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	500000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1100000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	700000	USD
CY2022Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-58900000	USD
CY2021Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-41000000.0	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4500000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-63400000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-41000000.0	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.20
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.20
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.84
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.84
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53000000.0	shares
CY2021Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-800000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-77500000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53000000.0	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48600000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48600000	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-63400000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-41000000.0	USD
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-14100000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-41800000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	781700000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16600000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-63400000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2500000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-14100000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	723300000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	642200000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10300000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-41000000.0	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4500000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-800000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	615200000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-63400000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-41000000.0	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1500000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1100000	USD
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-3300000	USD
CY2021Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1000000.0	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	600000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	300000	USD
CY2022Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	300000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	0	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	16600000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10300000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-15000000.0	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1000000.0	USD
CY2022Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-4100000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-2300000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2300000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2100000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-22600000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1800000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	7000000.0	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-10900000	USD
CY2022Q1	arvn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-600000	USD
CY2021Q1	arvn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-300000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-21200000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2500000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-57100000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-39000000.0	USD
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	263200000	USD
CY2021Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	240500000	USD
CY2022Q1	arvn	Proceeds From Maturities Of Marketable Securities ProceedsFromMaturitiesOfMarketableSecurities	273900000	USD
CY2021Q1	arvn	Proceeds From Maturities Of Marketable Securities ProceedsFromMaturitiesOfMarketableSecurities	33700000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2100000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1000000.0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	8600000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-207800000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2500000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4500000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2500000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4500000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-46000000.0	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-242300000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	112800000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	588400000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66800000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	346100000	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	100000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	100000	USD
CY2022Q1	arvn	Cash Cash Equivalents Restricted Cash And Marketable Securities CashCashEquivalentsRestrictedCashAndMarketableSecurities	1400000000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15000000.0	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2022Q1	arvn	Accounts Receivable After Allowance For Credit Loss Current Period Increase Decrease AccountsReceivableAfterAllowanceForCreditLossCurrentPeriodIncreaseDecrease	-15000000.0	USD
CY2021Q1	arvn	Accounts Receivable After Allowance For Credit Loss Current Period Increase Decrease AccountsReceivableAfterAllowanceForCreditLossCurrentPeriodIncreaseDecrease	0	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2021Q4	arvn	Collaboration Contract Asset And Other Assets CollaborationContractAssetAndOtherAssets	12500000	USD
CY2020Q4	arvn	Collaboration Contract Asset And Other Assets CollaborationContractAssetAndOtherAssets	0	USD
CY2022Q1	arvn	Collaboration Contract Asset And Other Assets Period Increase Decrease CollaborationContractAssetAndOtherAssetsPeriodIncreaseDecrease	-400000	USD
CY2021Q1	arvn	Collaboration Contract Asset And Other Assets Period Increase Decrease CollaborationContractAssetAndOtherAssetsPeriodIncreaseDecrease	0	USD
CY2022Q1	arvn	Collaboration Contract Asset And Other Assets CollaborationContractAssetAndOtherAssets	12100000	USD
CY2021Q1	arvn	Collaboration Contract Asset And Other Assets CollaborationContractAssetAndOtherAssets	0	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	740600000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	45100000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-24200000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-5500000	USD
CY2022Q1	arvn	Contract With Customer Liability Increase Decrease For Additions To Collaboration Agreements ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements	3000000.0	USD
CY2021Q1	arvn	Contract With Customer Liability Increase Decrease For Additions To Collaboration Agreements ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements	3000000.0	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	719400000	USD
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	42600000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	719400000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	150100000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	190000000.0	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	136500000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	100400000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	63400000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	34100000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	44900000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	719400000	USD
CY2021Q2	us-gaap	Pledged Financial Instruments Not Separately Reported Securities For Letter Of Credit Facilities PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForLetterOfCreditFacilities	4500000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25600000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23400000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12200000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1100000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10700000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13400000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12700000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1500000	USD
CY2021Q2	us-gaap	Land Subject To Ground Leases LandSubjectToGroundLeases	160000	sqft
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4500000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2021Q2	arvn	Base Lease Rent Period BaseLeaseRentPeriod	P10Y
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M6D
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	600000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	300000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	300000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2400000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3200000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1300000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2100000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2100000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	600000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	0	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6100000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	300000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	5800000	USD
CY2022Q1	arvn	Accrued Research And Development Expense Current AccruedResearchAndDevelopmentExpenseCurrent	18400000	USD
CY2021Q4	arvn	Accrued Research And Development Expense Current AccruedResearchAndDevelopmentExpenseCurrent	9500000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5100000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12400000	USD
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2200000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1200000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30200000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23100000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	200000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	200000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	200000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	200000	USD
CY2022Q1	arvn	Long Term Debt Maturity Year Six LongTermDebtMaturityYearSix	200000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	1000000.0	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	43.02
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5900000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.076
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.076
CY2021Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-63400000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-41000000.0	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53000000.0	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53000000.0	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48600000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48600000	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.20
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.20
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.84
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.84
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6600000	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5700000	shares

Files In Submission

Name	View Source	Status
0001655759-22-000016-index-headers.html	Edgar Link	pending
0001655759-22-000016-index.html	Edgar Link	pending
0001655759-22-000016.txt	Edgar Link	pending
0001655759-22-000016-xbrl.zip	Edgar Link	pending
arvinas-formofrsuagreement.htm	Edgar Link	pending
arvn-20220331.htm	Edgar Link	pending
arvn-20220331.xsd	Edgar Link	pending
arvn-20220331x10qex311.htm	Edgar Link	pending
arvn-20220331x10qex312.htm	Edgar Link	pending
arvn-20220331x10qex321.htm	Edgar Link	pending
arvn-20220331x10qex322.htm	Edgar Link	pending
arvn-20220331_cal.xml	Edgar Link	unprocessable
arvn-20220331_def.xml	Edgar Link	unprocessable
arvn-20220331_htm.xml	Edgar Link	completed
arvn-20220331_lab.xml	Edgar Link	unprocessable
arvn-20220331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pfizerarvinasamendmentno2r.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ARVN
Arvinas Inc Stock $arvn

2022 Q1 Form 10-Q Financial Statement

#000165575922000016 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARVN Arvinas Inc Stock $arvn

2022 Q1 Form 10-Q Financial Statement

#000165575922000016 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARVN
Arvinas Inc Stock $arvn